OpGen (OPGN)
(Delayed Data from NSDQ)
$2.64 USD
-0.06 (-2.23%)
Updated Jun 7, 2024 03:39 PM ET
After-Market: $2.63 -0.01 (-0.38%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Brokerage Reports
0 items in cart
OpGen, Inc. [OPGN]
Reports for Purchase
Showing records 101 - 106 ( 106 total )
Company: OpGen, Inc.
Industry: Medical Services
Merck Research Collaboration; 3Q16 Financial Results; Reiterate Buy and Adjusting Price Target to $2.50
Provider: H.C. Wainwright & Co., Inc.
Company: OpGen, Inc.
Industry: Medical Services
Merck Research Collaboration; 3Q16 Financial Results; Reiterate Buy and Adjusting Price Target to $2.50
Provider: Rodman & Renshaw, Co.
Company: OpGen, Inc.
Industry: Medical Services
2Q16 Financial Results Reported; Reiterate Buy; Raising Price Target to $3.25
Provider: Rodman & Renshaw, Co.
Company: OpGen, Inc.
Industry: Medical Services
2Q16 Financial Results Reported; Reiterate Buy; Raising Price Target to $3.25
Provider: H.C. Wainwright & Co., Inc.
Company: OpGen, Inc.
Industry: Medical Services
Initiating at Buy and $2.50 Target
Provider: Rodman & Renshaw, Co.
Company: OpGen, Inc.
Industry: Medical Services
We are initiating coverage of OpGen, Inc. with a Buy rating and a 12-month price target of $2.50
Provider: H.C. Wainwright & Co., Inc.